NEW YORK (Reuters Health) – Starting estrogen-progestogen therapy close to menopause may increase the risk of breast cancer, even with short-duration treatment, according to a report in the…
NEW YORK (Reuters Health) – In patients with atrial fibrillation (AF), the antiarrhythmic dronedarone is less effective than amiodarone at maintaining sinus rhythm, but it has fewer adverse…
NEW YORK (Reuters Health) – Although dimenhydrinate can reduce vomiting in children with acute gastroenteritis, it does not improve oral rehydration or clinical outcomes, according to a report…
NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive…
NEW YORK (Reuters Health) – Perioperative corticosteroids reduce the risk of postoperative atrial fibrillation (AF) by more than 50% in patients undergoing cardiac surgery, according to a meta-analysis…
NEW YORK (Reuters Health) – Findings from a systematic review indicate that while tamoxifen, raloxifene, and tibolone all reduce the risk of primary breast cancer, the drugs differ…
NEW YORK (Reuters Health) – A dexamethasone-based protocol can cut the risk of relapse and improve survival in high-risk children with acute lymphoblastic leukemia (ALL), with fewer side…
NEW YORK (Reuters Health) – Thiazolidinedione treatment of diabetes in older adults is associated with an increased fracture risk, according to a report in the August issue of…
NEW YORK (Reuters Health) – Intracoronary streptokinase (ICSK) given immediately after percutaneous coronary intervention (PCI) reduces long-term myocardial infarction size and improves left ventricular volumes and function, Turkish…
NEW YORK (Reuters Health) – Giving low-dose dopamine to brain-dead donors can improve graft function after kidney transplantation, according to trial findings reported in the Journal of the…